GB0405101D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0405101D0 GB0405101D0 GBGB0405101.7A GB0405101A GB0405101D0 GB 0405101 D0 GB0405101 D0 GB 0405101D0 GB 0405101 A GB0405101 A GB 0405101A GB 0405101 D0 GB0405101 D0 GB 0405101D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0405101.7A GB0405101D0 (en) | 2004-03-06 | 2004-03-06 | Compounds |
| PCT/GB2005/000759 WO2005085232A1 (en) | 2004-03-06 | 2005-03-01 | Hydantoin derivatives for use as tace and aggrecanase inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0405101.7A GB0405101D0 (en) | 2004-03-06 | 2004-03-06 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0405101D0 true GB0405101D0 (en) | 2004-04-07 |
Family
ID=32088856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0405101.7A Ceased GB0405101D0 (en) | 2004-03-06 | 2004-03-06 | Compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0405101D0 (en) |
| WO (1) | WO2005085232A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102112440A (en) | 2008-05-30 | 2011-06-29 | 武田药品工业株式会社 | Heterocyclic compound |
| HUE030114T2 (en) | 2010-07-08 | 2017-04-28 | Kaken Pharma Co Ltd | N-hydroxyformamide derivative and pharmaceutical containing same |
| HU1000676D0 (en) * | 2010-12-17 | 2011-02-28 | Pharmahungary 2000 Kft | Inhibitors of matrix metalloproteinase, pharmaceutical compositions thereof and use of them for preventing and treating diseases where the activation of mmp is involved |
| JP5957077B2 (en) * | 2011-07-13 | 2016-07-27 | ノバルティス アーゲー | 4-Piperidinyl compounds for use as tankyrase inhibitors |
| TWI568726B (en) | 2011-12-09 | 2017-02-01 | Kaken Pharma Co Ltd | Pyridine derivatives and pharmaceuticals containing them |
| WO2014196623A1 (en) * | 2013-06-07 | 2014-12-11 | 科研製薬株式会社 | (+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2h)-yl)methyl]imidazolidine-2,4-dione and drug containing same |
| JO3501B1 (en) | 2014-12-22 | 2020-07-05 | Servier Lab | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003228701A1 (en) * | 2002-04-25 | 2003-11-10 | Bristol-Myers Squibb Company | Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| WO2003104220A1 (en) * | 2002-06-11 | 2003-12-18 | Bristol-Myers Squibb Company | Asymetric synthesis of amino-pyrrolidinones |
| GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
-
2004
- 2004-03-06 GB GBGB0405101.7A patent/GB0405101D0/en not_active Ceased
-
2005
- 2005-03-01 WO PCT/GB2005/000759 patent/WO2005085232A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005085232A1 (en) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0405933D0 (en) | Compounds | |
| EP1737831A4 (en) | Neurologically-active compounds | |
| GB0405937D0 (en) | Compounds | |
| EP1755617A4 (en) | Perfluorocarbon-soluble compounds | |
| GB0405193D0 (en) | Compounds | |
| GB0405272D0 (en) | Compounds | |
| GB0405267D0 (en) | Compounds | |
| GB0405101D0 (en) | Compounds | |
| GB0401269D0 (en) | Compounds | |
| GB0408772D0 (en) | Compounds | |
| GB0405280D0 (en) | Compounds | |
| GB0405893D0 (en) | Compounds | |
| GB0403593D0 (en) | Compounds | |
| GB0403595D0 (en) | Compounds | |
| GB0406916D0 (en) | Compounds | |
| GB0403267D0 (en) | Compounds | |
| GB0403334D0 (en) | Compounds | |
| GB0403993D0 (en) | Compounds | |
| GB0403998D0 (en) | Compounds | |
| GB0404081D0 (en) | Compounds | |
| GB0404083D0 (en) | Compounds | |
| GB0404084D0 (en) | Compounds | |
| GB0404104D0 (en) | Compounds | |
| GB0404215D0 (en) | Compounds | |
| GB0405099D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |